Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of obesity and metformin on subcutaneous Lewis lung carcinoma cell-line tumors in mice

ABSTRACT: Effect of obesity and metformin on subcutaneous Lewis lung carcinoma cell-line tumors in mice

PROVIDER: PRJEB34297 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3510570.fastq.gz	Fastqsanger.gz
	ERR3510561.fastq.gz	Fastqsanger.gz
	ERR3510571.fastq.gz	Fastqsanger.gz
	ERR3510562.fastq.gz	Fastqsanger.gz
	ERR3510572.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 38

Similar Datasets

Transcriptomes of CD4+ Treg and non-Treg T cells of subcutaneous cell-line tumors of C57BL/6J mice with/without obesity/metformin treatment

Project description:Transcriptomes of CD4+ Treg and non-Treg T cells of subcutaneous cell-line tumors of C57BL/6J mice with/without obesity/metformin treatment

| PRJEB36478 | ENA

Metformin Regulates Metabolic and Non-Metabolic Pathways in Skeletal Muscle and Subcutaneous Adipose Tissues of Older Adults

Project description:Administration of metformin increases healthspan and lifespan in model systems and evidence from clinical trials and observational studies suggests that metformin delays a variety of age-related morbidities. Although metformin has been shown to modulate multiple biological pathways at the cellular level, these pleiotropic effects of metformin on the biology of human aging have not been studied. We studied ~70-year-old participants (n=14), in a randomized, double-blind, placebo-controlled, crossover trial in which they were treated with 6 weeks each of metformin and placebo. Following each treatment period, skeletal muscle and subcutaneous adipose tissue biopsies were obtained, and a mixed-meal challenge test was performed. As expected, metformin therapy lowered 2-hour glucose, insulin AUC, and insulin secretion compared to placebo. Using FDR<0.05, 647 genes were differentially expressed in muscle and 146 genes were differentially expressed in adipose tissue. Both metabolic and non-metabolic pathways were significantly influenced, including pyruvate metabolism and DNA repair in muscle and PPAR & SREBP signaling, mitochondrial fatty acid oxidation and collagen trimerization in adipose. While each tissue had, a signature reflecting its own function, we identified a cascade of predictive upstream transcriptional regulators, including mTORC1, MYC, TNF, TGFß1 and miRNA-29b, that may explain tissue-specific transcriptomic changes in response to metformin treatment. This study provides the first evidence that, in older adults, metformin has metabolic and non-metabolic effects linked to aging. These data can inform the development of biomarkers for the effects of metformin, and potentially other drugs, on key aging pathways. Key words: Aging, biguanides, gene expression, metabolism, upstream regulators

2017-12-12 | GSE107894 | GEO

Investigation of placental gene expression in obese women exposed to Metformin during pregnancy

Project description:Maternal obesity in pregnancy is associated with increased birth-weight, obesity and premature mortality in adult offspring. The Effect of Metformin on Maternal and Fetal Outcomes in Pregnant Obese Women (EMPOWaR) trial was a randomised, double-blind, placebo-controlled trial carried out to determine whether exposure to Metformin would affect the offspring birth-weight centile. Obese women exposed to Metformin had increased insulin sensitivity at 36 weeks of pregnancy, but there were no differences in offspring birthweight. We obtained the placentas from these women to determine whether there were differences in expression of genes regulating fetal growth and metabolism. In a complementary study we investigated DNA methylation in the same samples.

2019-01-31 | E-MTAB-6418 | biostudies-arrayexpress

Melanerpes lewis

Project description:Melanerpes lewis

| PRJNA960563 | ENA

Investigation of placental DNA methylation in obese women exposed to Metformin during pregnancy

Project description:Maternal obesity in pregnancy is associated with increased birth-weight, obesity and premature mortality in adult offspring. The Effect of Metformin on Maternal and Fetal Outcomes in Pregnant Obese Women (EMPOWaR) trial was a randomised, double-blind, placebo-controlled trial carried out to determine whether exposure to Metformin would affect the offspring birth-weight centile. Obese women exposed to Metformin had increased insulin sensitivity at 36 weeks of pregnancy, but there were no differences in offspring birthweight. We obtained the placentas from these women to determine whether there were differences in DNA methylation of genes regulating fetal growth and metabolism. In a related study we investigated the gene expression in the same samples.

2018-11-01 | E-MTAB-6421 | biostudies-arrayexpress

Effect of obesity on genome methylation of lung carcinoma cells grown as subcutaneous tumors in young male C57BL/6 mice

Project description:Luciferase-expressing Lewis lung carcinoma (LLC-Luc/LL-2; ATCC CRL-1642-LUC2) or KPN1.1 lung carcinoma (DOI 0.1016/j.crmeth.2021.100080) cell-lines were grown as subcutaneous tumors after injection in syngeneic male C57BL/6 of ~6 months age that had been on normal or high-fat diet for ~4 months and which they were kept on during the rest of the experiment. About 19-29 days later, tumors were harvested to isolate the carcinoma cells by flow cytometry to extract DNA/RNA from for genome methylation and transcriptome RNA sequencing. All LLC-Luc samples were from one mouse experiment, all but one (sample 12) of the KPN1.1 samples were from the same mouse experiment. DNA isolation and array experiments were performed in one batch for all samples.

2024-12-31 | E-MTAB-13516 | biostudies-arrayexpress

Microarray analyses of the effects of prenatal metformin exposure on the gene expression profile of liver, brain and subcutaneous adipose tissue of neonatal mice

Project description:The aim of the study was to characterise the effects of prenatal metformin exposure on a tissue gene expression level in mice. The data consists of two models, regular diet (study I) and high fat diet (study II) model. In both models, metformin (300 mg/kg) or control agent (water) was administered to pregnant female mice from the embryonic day E0.5 untill E17.5. In the high fat diet model, the dams had been on a high fat diet (60% of fat) for one month prior to and during the gestation. The diet was changed to regular diet from E18.5. The pups were sacrificed by decapitation at postnatal day 4 and brain (study I), liver (studies I and II) and subcutaneous adipose tissue (study II) were taken for further microarray analyses. In study I,there are 3 replicates in each group of interest: brain_male_ctrl; brain_male_met; liver_male_ctrl; liver_male_met; liver_female_ctrl; liver_female_met. In study II, there are 6 replicates in each group of interest: liver_male_ctrl; liver_male_met; wat_male_ctrl; wat_male_met.

2014-12-11 | E-GEOD-62612 | biostudies-arrayexpress

Microarray analyses of the effects of prenatal metformin exposure on the gene expression profile of liver, brain and subcutaneous adipose tissue of neonatal mice

2014-12-11 | GSE62612 | GEO

Single-cell RNA sequencing reveals recruitment of the M2-like CCL8high macrophages in Lewis lung carcinoma-bearing mice following hypofractionated radiotherapy

Project description:Tumor-associated macrophages (TAMs) are a crucial factor in reprogramming the tumor microenvironment following radiotherapy. The mechanisms underlying this process remain to be elucidated. We used single cell RNA sequencing (scRNA-seq) to investigate the effects of hypofractionated radiotherapy on macrophages dynamics in a subcutaneous Lewis lung carcinoma (LLC) murine model.

2024-04-03 | GSE256051 | GEO

Lewis Lung Carcinoma UROD

Project description:Lewis Lung Carcinoma UROD

| PRJNA578483 | ENA